Antoine Bichat

Antoine Bichat

Auto-generated profile, based on publicly available information

Antoine Bichat

Spotlight Medical, Paris, France

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2020 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
ABAntoine Bichat
Antoine Bichat
JPJonathan Plassais
Jonathan Plassais
CAChristophe Ambroise
Christophe Ambroise
MMMahendra Mariadassou
Mahendra Mariadassou
We consider the problem of incorporating evolutionary information (e.g., taxonomic or phylogenic trees) in the context of metagenomics differential analysis. Recent results published in the literature propose different ways to leverage the tree structure to increase the detection rate of differentially abundant taxa. Here, we propose instead to use a different hierarchical structure, in the form of a correlation-based tree, as it may capture the structure of the data better than the phylogeny. We first show that the correlation tree and the phylogeny are significantly different before turning to the impact of tree choice on detection rates. Using synthetic data, we show that the tree does have an impact: smoothing p-values according to the phylogeny leads to equal or inferior rates as smoothing according to the correlation tree. However, both trees are outperformed by the classical, non-hierarchical, Benjamini–Hochberg (BH) procedure in terms of detection rates. Other procedures may use the hierarchical structure with profit but do not control the False Discovery Rate (FDR) a priori and remain inferior to a classical Benjamini–Hochberg procedure with the same nominal FDR. On real datasets, no hierarchical procedure had significantly higher detection rate that BH. Intuition advocates that the use of hierarchical structures should increase the detection rate of differentially abundant taxa in microbiome studies. However, our results suggest that current hierarchical procedures are still inferior to standard methods and more effective procedures remain to be invented.

1 October 2025 in Journal of Clinical Oncology
Verified
Journal Article
Open access
FBFrancois-Clement Bidard
Francois-Clement Bidard
GGGrégoire Gessain
Grégoire Gessain
TBThomas BACHELOT
Thomas BACHELOT
LFLucie Frechin
Lucie Frechin
AVAnne Vincent-Salomon
Anne Vincent-Salomon
FAFabrice André
Fabrice André
PURPOSE: Escalation of adjuvant systemic therapies (eg, with cyclin-dependent kinase 4 and 6 inhibitors) is now indicated for patients with clinically defined high-risk estrogen receptor–positive (ER+)/human epidermal growth factor receptor 2–negative (HER2–) early breast cancer, although it is unclear which will benefit from additional therapies. We developed and validated a prognostic clinicopathologic assay identifying a subpopulation of high-risk patients with good prognosis after standard adjuvant therapies, who may safely forgo treatment escalation. METHODS: We trained a Cox proportional-hazards model that integrates clinicopathologic variables with features derived from digitized hematoxylin-and-eosin–stained resection slides from a retrospective data set. The model assigns each patient to a low-risk or not low-risk group, reflecting their predicted risk of recurrence. Blind validation was successively performed on high-risk patients from the prospective trials CANTO (ClinicalTrials.gov identifier: NCT01993498 ) and UNIRAD (ClinicalTrials.gov identifier: NCT01805271 ). RESULTS: Built on data from 6,164 patients with ER+/HER2– early-stage breast cancer, this assay integrates four clinicopathologic variables, and 10 slide-derived features capturing tumor architecture, microenvironment, and proliferation. In the combined CANTO and UNIRAD trials (n = 633), 95.4% of the low-risk patients remained free of distant recurrence and death from breast cancer at 9 years, compared with 76.8% for the not low-risk group. Distant recurrence-free interval (subdistribution hazard ratio [HR], 0.21 [95% CI, 0.09 to 0.52]; P < .001), invasive disease-free survival (HR, 0.31 [95% CI, 0.16 to 0.60]; P < .001), and overall survival (HR, 0.35 [95% CI, 0.13 to 0.97]; P = .044) were all statistically significant. Multivariate analyses showed that the assay provided predictive information beyond clinicopathologic variables. Analytical validation showed robustness to data variability. CONCLUSION: The assay demonstrated robust performance in identifying a core group of patients with high-risk ER+/HER2– breast cancer for whom additional adjuvant treatment may be futile.

12 September 2021 in Computational Statistics
Verified
Journal Article
Open access
PDF file
ABAntoine Bichat
Antoine Bichat
CAChristophe Ambroise
Christophe Ambroise
MMMahendra Mariadassou
Mahendra Mariadassou
Statistical testing is classically used as an exploratory tool to search for association between a phenotype and many possible explanatory variables. This approach often leads to multiple testing under dependence. We assume a hierarchical structure between tests via an Ornstein-Uhlenbeck process on a tree. The process correlation structure is used for smoothing thep-values. We design a penalized estimation of the mean of the Ornstein-Uhlenbeck process forp-value computation. The performances of the algorithm are assessed via simulations. Its ability to discover new associations is demonstrated on a metagenomic dataset. The corresponding R package is available fromhttps://github.com/abichat/zazou.



4 April 2026
Verified
Thesis
Closed access
ABAntoine Bichat
Antoine Bichat
Cette thèse porte sur l'inclusion d'informations hiérarchiques dans des procédures de détection d'abondance différentielle sur des données métagénomiques. Les différents taxons qui composent le microbiote sont généralement accompagnés d'un arbre, comme la taxonomie ou la phylogénie, qui traduit une proximité biologique entre eux. Il est alors naturel de vouloir tirer parti de cette information hiérarchique afin d'augmenter la puissance des tests de détection de taxons différentiellement abondants. Dans un premier temps, nous nous sommes intéressés aux performances des procédures hiérarchiques existantes et à l'impact du choix de l'arbre sur celles-ci. Dans un second temps, nous avons développé notre propre méthode hiérarchique de détection d'abondance différentielle. Celle-ci modélise les z-scores associés à chaque taxon comme la réalisation d'un processus d'Ornstein-Uhlenbeck sur arbre avec sauts dans la valeur optimale du processus puis effectue une régression de type lasso pour déterminer les positions et intensités optimales des sauts.